CCL20-modulated PMN-MDSCs secreted amounts of CXCL2 and activated NOTCH1/HEY1 signaling pathway in breast cancer cells by binding to CXCR2, leading to the increase of ALDH+ BCSCs. This evidence concerns the gene CCL20 and breast carcinoma.